June 2 (Reuters) - Nanoform Finland Plc NANOFH.HE :
* NANOFORM RAISES ITS MID-TERM BUSINESS TARGETS FOR 2025
* 2025 TARGET: TO NANOFORM ANNUALLY AT LEAST 70 NEW ACTIVE
PHARMACEUTICAL INGREDIENTS, OR `APIS' (40% INCREASE FROM
PREVIOUS TARGET OF AT LEAST 50 NEW APIS ANNUALLY)
* 2025 TARGET: TO HAVE IN PLACE 35 OPERATING PRODUCTION
LINES, OF
WHICH 7 TO 14 ARE EXPECTED TO BE GMP COMPLIANT
* 2025 TARGET: TO HAVE 200-250 EMPLOYEES (0-25% INCREASE
FROM
PREVIOUS TARGET OF ABOUT 200)
Source text for Eikon: ID:nWkrlvbbl
Further company coverage: NANOFH.HE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))